Skip to content. | Skip to navigation

Personal tools

Sections

Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1


Secondary managing bodies

logo ENSL logo ucb1

You are here: Home / About us / News

News

Covid-19: infection-vaccination combination best protects against reinfection with SARS-CoV-2

Several CIRI teams carried out this work, published in the journal Science Translational Medicine.

Read More…

Le CIRI reçoit la SFI

Le CIRI reçoit le bureau de la SFI vendredi 20 janvier.

Read More…

Publications 2021

Découvrez le CIRI à travers une sélection de ses publications de l'année 2021

Read More…

IRCI 2022

Immune Response in Cancer and Infection

Read More…

IRCI 2022

Immune Responses in Cancer and Infection

Read More…

Web Conférence Grand Public

La Société Francaise de Virologie vous invite à une Web Conférence Grand Public présentée par Dr. Hubert Laude

Read More…

Séminaire CIRI: Dr. Suzana Salcedo

 Dr. Suzana Salcedo (IBCP Lyon; MMSB): "Studying nosocomial bacterial pathogenesis: old toxins, new functions"

Read More…

Le CIRI au 23ème ANRS | EID AC42

Le CIRI est représenté, ces mardi 23 et mercredi 24 mai 2023, au meeting du Réseau National des Hépatites virales qui se déroule à Paris.

Read More…

Inauguration of the Rosalind Franklin building

The new Rosalind Franklin building was inaugurated on October 25, in the presence of sponsors and managing bodies representatives, journalists and CIRI and SFR staff. Here's a look back at the day's events.

Read More…

Sidaction donors discover CIRI with the LP2L team

On October 12, 2023, Sidaction donors visited the laboratory of the LP2L team (A. Cimarelli, L. Etienne). Here's a look back at this successful moment of sharing.

Read More…

2023 PEPR MIE recipients : CIRI involved in 6 projects

Among the 11 laureates of the PEPR MIE 2023 call for projects (ANRS|Emerging Infectious Diseases), 6 projects involve CIRI teams. Their common aim is to better understand, prevent and control the emergence or re-emergence of infectious diseases.

Read More…

Launch of the Chaire industrielle REVIDA

On october 11, the Chaire industrielle REVIDA about respiratory infectious diseases, led by the researcher Sophie Trouillet-Assant (UCBL/HCL), was officially launched by the Université Claude Bernard Lyon 1, the Hospices Civils de Lyon, and bioMérieux, with the support of the Agence nationale de la recherche. It should enable the improvement of the capacity of health systems to face the emerging of new respiratory diseases.

Read More…

Voeux 2024

Le CIRI vous présente ses meilleurs voeux pour l'année 2024.

Read More…

Demain, mais en mieux !

Meet with Cyrille Mathieu at the Yggdrasil festival, to learn all about viruses!

Read More…

VirPath team wins two awards of research and innovation

The VirPath team was awarded two times during the 2023 research and innovation awards ceremony of the Université Claude Bernard Lyon 1. We look back at these awards and on the research program of the International Associate Laboratory RESPIVIR France-Canada.

Read More…

"Têtes chercheuses": research in cancerology, presented by the fondation ARC

The ARC Foundation brings together 5 leading cancer researchers for a 45-minute program. It will give the floor to experienced researchers and young talents, all ready to take up, together, the challenges of curing more patients.

Read More…

Rare Disease Day 2024

February 29, 2024 is Rare Disease Day. This is an opportunity to thank the clinicians and researchers who are advancing research on this subject at CIRI, as well as our patients!

Read More…

Kick-off of the industrial chair VIRESP

On Wednesday January 24, 2024, Université Claude Bernard Lyon 1 (UCBL), Hospices Civils de Lyon (HCL) (HCL), the French National Research Agency (ANR) and Sanofi officially launched the the VIRESP industrial chair, a research project focusing on the development of techniques and tools for analyzing the risk of infection and the morbidity rate of diseases in different populations, but also to determine the benefits of vaccination programs.

Read More…

The LIA RESPIVIR was honored during the meeting of the French and Quebec Prime Ministers

The RESPIVIR France - Canada International Research Laboratory was very well received at the 21st alternating meeting between the Quebec and French prime ministers, François Legault and Gabriel Attal, which took place in Quebec from April 10 to 12.

Read More…

David Durantel is the new President Elect of the International Society for Antiviral Research

David Durantel (HepVir team and virology specialty coordinator) was elected President Elect of the ISAR (International Society for Antiviral Research), thus strenghtening the role of CIRI researchers in the international area of virology and antiviral research!

Read More…

Recent books published by members of the CIRI

Members of the CIRI contributed to two books that were recently published. One is about the history of microbiology, and the other tackles research progress linked to the COVID-19 pandemic.

Read More…

Impact of vaccination on induction of mucosal immunity with mRNA vaccines against Covid-19 epidemic.

Teams from the Immunology Department of the Pitié-Salpêtrière AP-HP hospital, Inserm and Sorbonne University, coordinated by Prof. Guy Gorochov, have conducted a study on the ability of Covid-19 mRNA vaccines to induce a mucosal immune response. CIRI members took part in this study. The results were published in JAMA Network Open on April 23, 2024.

Read More…

Autophagy, a key role in the pathophysiology of Crohn's disease

In a new study published in the journal Autophagy, CIRI researchers have shown for the first time that, in patients with Crohn's disease, the expression of autophagic gene variants strongly affects autophagic dynamics, known as autophagic flux.

Read More…

The CIRI at Pint of Science 2024

Every year, the Pint of Science festival brings together scientists and the curious for 3 evenings of popularizing science in bars. Here's a look back at CIRI doctoral students' participation in the 2024 edition!

Read More…

Endogenous retroviruses make a stop in Zaragoza

Last year more than 40 researchers gathered in Rome for the first HERVCOV project annual meeting. This year it's time to visit another of the project partners' cities and the 2nd Annual Meeting will be held in Zaragoza, headquarters of the Instituto Aragonés de Ciencias de la Salud (IACS) and IIS Aragón.

Read More…